- Home
- LVLU vs CLGN Comparison
LVLU vs CLGN Comparison
Compare LVLU & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- CLGN
- Stock Information
- Founded
- LVLU 1996
- CLGN 2004
- Country
- LVLU United States
- CLGN Israel
- Employees
- LVLU N/A
- CLGN N/A
- Industry
- LVLU Catalog/Specialty Distribution
- CLGN Industrial Specialties
- Sector
- LVLU Consumer Discretionary
- CLGN Health Care
- Exchange
- LVLU Nasdaq
- CLGN Nasdaq
- Market Cap
- LVLU 18.4M
- CLGN 19.1M
- IPO Year
- LVLU 2021
- CLGN N/A
- Fundamental
- Price
- LVLU $0.28
- CLGN N/A
- Analyst Decision
- LVLU Hold
- CLGN Strong Buy
- Analyst Count
- LVLU 2
- CLGN 2
- Target Price
- LVLU $1.00
- CLGN $11.50
- AVG Volume (30 Days)
- LVLU 778.0K
- CLGN 103.1K
- Earning Date
- LVLU 08-13-2025
- CLGN 08-19-2025
- Dividend Yield
- LVLU N/A
- CLGN N/A
- EPS Growth
- LVLU N/A
- CLGN N/A
- EPS
- LVLU N/A
- CLGN N/A
- Revenue
- LVLU $302,783,000.00
- CLGN $2,472,000.00
- Revenue This Year
- LVLU N/A
- CLGN $2,177.67
- Revenue Next Year
- LVLU $2.53
- CLGN $56.52
- P/E Ratio
- LVLU N/A
- CLGN N/A
- Revenue Growth
- LVLU N/A
- CLGN N/A
- 52 Week Low
- LVLU $0.22
- CLGN $1.31
- 52 Week High
- LVLU $1.88
- CLGN $5.48
- Technical
- Relative Strength Index (RSI)
- LVLU 34.10
- CLGN 41.28
- Support Level
- LVLU $0.22
- CLGN $1.31
- Resistance Level
- LVLU $0.56
- CLGN $1.54
- Average True Range (ATR)
- LVLU 0.09
- CLGN 0.14
- MACD
- LVLU -0.02
- CLGN -0.00
- Stochastic Oscillator
- LVLU 15.25
- CLGN 14.21
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.